Citadel Aurobindo Biotech Limited - Company Profile

It is a pharma public limited company based in Chennai - 600 042., Tamil Nadu, India, established in 2002.
2002 Chennai - 600 042., Tamil Nadu, India Active
Last Updated:
Access Report
About Citadel Aurobindo Biotech Limited

Citadel Aurobindo Biotech Limited, a active public limited company, was established on 22 March 2002 in Chennai - 600 042., Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24231TN2002PLC048652. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

It upholds a active non-compliant status. Its leadership includes Mruthyunjaya Reddy Kapuluru (Director), Rajiv Krishnamurthy (Director), Sardar Sulakshan Singh (Director). Past directors included Ramkumar Krishnamurthy Anekar, Sadananda Reddy Sannareddy, Padmanoor Harihara Rao Rajendra Rao. It holds no open charges and ₹40.00 Cr settled loans. Its latest AGM occurred on 05 September 2020, with the balance sheet filed on 31 March 2019. It is based at 43, Main Road,Velacherry, Velacherry,, Chennai - 600 042., Tamil Nadu, 600042.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN2002PLC048652

  • Registration Number

    048652

  • Incorporation Date

    22 March 2002

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 23 Year, 11 Months
  • Last Filing with ROC 31 Mar 2019
  • Satisfied Charges ₹ 40.00 Cr
  • Revenue Growth **** -44.42%
  • Profit Growth **** -9583.74%
  • Ebitda **** -432.91%
  • Net Worth -0.01%
  • Total Assets -76.73%
Company report

Citadel Aurobindo Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Citadel Aurobindo Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Citadel Aurobindo Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Mruthyunjaya Reddy Kapuluru Director 15 Apr 2002 Current
Rajiv Krishnamurthy Director 06 Feb 2007 Current
Sardar Sulakshan Singh Director 04 Dec 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 16 Sep 2006 Past
Pramod Abcsdd Director 30 Mar 2007 Past
Pramod Abcsdd Nominee Director 25 Jan 2007 Past
Pramod Abcsdd Nominee Director 12 Sep 2006 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Citadel Aurobindo Biotech.

Citadel Aurobindo Biotech Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 44.42% decrease. The company also saw a substantial fall in profitability, with a 9583.74% decrease in profit. The company's net worth dipped by a decrease of 0.01%.

Citadel Aurobindo Biotech revenue growth over time
Citadel Aurobindo Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -44.42%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -76.73%
*******
*******
*******
*******
Profit or Loss
*******
 -9583.74%
*******
*******
*******
*******
Net Worth
*******
 -0.01%
*******
*******
*******
*******
EBITDA
*******
 -432.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Citadel Aurobindo Biotech?

In 2019, Citadel Aurobindo Biotech had a public holding of 100.00%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹400,000,000.00

Charges Breakdown by Lending Institutions
  • Uti Bank Limited : 30.00 Cr
  • Standard Chartered Bank : 10.00 Cr
Latest Charge Details
Date Lender Amount Status
24 Jan 2003 Uti Bank Limited ₹30.00 Cr Satisfied
21 Oct 2002 Standard Chartered Bank ₹10.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Citadel Aurobindo Biotech?

Unlock and access historical data on people associated with Citadel Aurobindo Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Citadel Aurobindo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citadel Aurobindo Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Citadel Aurobindo Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Citadel Aurobindo Biotech Limited last Annual general meeting of members was held on 05 Sep 2020 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Citadel Aurobindo Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai. was completed.

  • Director Appointment

    The activity Rajiv Krishnamurthy was appointed as a Director was appointed as a Director on 06 Feb 2007 & has been associated with this company since 19 years 21 days . was completed.

  • Charges

    A charge registered on 24 Jan 2003 via Charge ID 90293101 with Uti Bank Limited was fully satisfied on 11 Dec 2006. was recorded as a recent event.

  • Director Appointment

    The activity Sardar Sulakshan Singh was appointed as a Director was appointed as a Director on 04 Dec 2006 & has been associated with this company since 19 years 2 months . was completed.

  • Charges

    A charge registered on 21 Oct 2002 via Charge ID 90293065 with Standard Chartered Bank was fully satisfied on 31 Oct 2006. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Citadel Aurobindo Biotech Limited?

The CIN of Citadel Aurobindo Biotech Limited is U24231TN2002PLC048652.

Where is Citadel Aurobindo Biotech Limited headquartered?

Citadel Aurobindo Biotech Limited is headquartered at 43, Main Road,Velacherry, Velacherry,, Chennai - 600 042., Tamil Nadu, 600042.

When was Citadel Aurobindo Biotech Limited incorporated?

Citadel Aurobindo Biotech Limited was incorporated on 22 March 2002.

Who are the current directors of Citadel Aurobindo Biotech Limited?

The current directors of Citadel Aurobindo Biotech Limited are

What is the primary industry of Citadel Aurobindo Biotech Limited?

The primary industry of Citadel Aurobindo Biotech Limited is Hospital And Medical Care.

Is Citadel Aurobindo Biotech Limited a listed company?

Citadel Aurobindo Biotech Limited is unlisted.

What is the capital structure of Citadel Aurobindo Biotech Limited?

The authorized capital of Citadel Aurobindo Biotech Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Citadel Aurobindo Biotech Limited?

The compliance status of Citadel Aurobindo Biotech Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available